Protara Therapeutics (TARA) Preferred Dividend Payments (2013 - 2017)
Protara Therapeutics (TARA) posted quarterly Preferred Dividend Payments of $6.7 million for Q3 2017, down 43.96% quarter-over-quarter from $12.0 million in Q4 2014.
Protara Therapeutics (TARA) Preferred Dividend Payments (2013 - 2017) Analysis & Trends
Protara Therapeutics (TARA) has reported Preferred Dividend Payments for 3 consecutive years, with $6.7 million the latest figure, recorded in Q3 2017.
- In Q3 2017, Preferred Dividend Payments changed N/A year-over-year to $6.7 million; the TTM figure through Sep 2017 stood at $16.5 million (up 41.6% YoY), while the FY2014 annual figure was $6.4 million, up 203.82% from the prior year.
- Preferred Dividend Payments fell to $6.7 million in Q3 2017 per TARA's latest filing, from $12.0 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $12.0 million in Q4 2014 and bottomed at -$10.7 million in Q4 2013.
- Historically, Preferred Dividend Payments has averaged $1.5 million across 3 years, with a median of $1.5 million in 2013.
- On a YoY basis, Preferred Dividend Payments climbed as much as 212.54% in 2014 and fell as far as 247.86% in 2014.
- Protara Therapeutics' Preferred Dividend Payments stood at -$10.7 million in 2013, then surged by 212.54% to $12.0 million in 2014, then slumped by 43.96% to $6.7 million in 2017.
- Business Quant data shows TARA's Preferred Dividend Payments at $6.7 million in Q3 2017, $12.0 million in Q4 2014, and -$2.3 million in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Protara Therapeutics | 234.56 Mn | 234.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 6.75 Mn |
| Dec 31, 2014 | 12.04 Mn |
| Sep 30, 2014 | -2.28 Mn |
| Jun 30, 2014 | 1.90 Mn |
| Mar 31, 2014 | 1.51 Mn |
| Dec 31, 2013 | -10.70 Mn |
| Sep 30, 2013 | 1.54 Mn |